154 related articles for article (PubMed ID: 18447836)
1. [Changes of elastic properties of peripheral vessels and parameters of endothelial function at the background of the use of fixed combination of perindopril and indapamide in patients with hypertensive disease].
Martynov AI; Sharkova NE; Obukhov AA
Kardiologiia; 2008; 48(4):25-8. PubMed ID: 18447836
[No Abstract] [Full Text] [Related]
2. Effects of blood pressure control with perindopril/indapamide on the microcirculation in hypertensive patients.
Debbabi H; Bonnin P; Levy BI
Am J Hypertens; 2010 Oct; 23(10):1136-43. PubMed ID: 20508624
[TBL] [Abstract][Full Text] [Related]
3. [Comparative efficacy of fixed dose combinations of perindopril with indapamide and captopril with hydrochlorothiazide in patients with high risk hypertension].
Nedogoda SV; Marchenko IV; Chaliabi TA; Tsoma VV; Brel' UA; Prokhorova EA
Kardiologiia; 2005; 45(11):24-6. PubMed ID: 16353060
[TBL] [Abstract][Full Text] [Related]
4. What can be learned from the experience with the fixed low-dose combination of perindopril/indapamide in the treatment of hypertension?
Waeber B
Expert Opin Pharmacother; 2005 Oct; 6(13):2291-9. PubMed ID: 16218889
[TBL] [Abstract][Full Text] [Related]
5. Comparison of different therapeutic strategies in hypertension: a low-dose combination of perindopril/indapamide versus a sequential monotherapy or a stepped-care approach.
Mourad JJ; Waeber B; Zannad F; Laville M; Duru G; Andréjak M;
J Hypertens; 2004 Dec; 22(12):2379-86. PubMed ID: 15614033
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of different approaches to the treatment of arterial hypertension: combination treatment with low dose perindopril/indapamide versus sequential treatment of stepped-dose treatment].
Andréjak M; Zannad F; Laville M; Duru G; Mourad JJ; Waeber B
Therapie; 2003; 58(4):351-2. PubMed ID: 14679674
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of an oral fixed low-dose perindopril 2 MG/indapamide 0.625 MG combination: a randomized, double-blind, placebo-controlled study in elderly patients with mild to moderate hypertension.
Castaigne A; Chalmers J; Morgan T; Chastang C; Feldmann L; Guez D
Clin Exp Hypertens; 1999 Oct; 21(7):1097-110. PubMed ID: 10513830
[TBL] [Abstract][Full Text] [Related]
8. Fixed combination of perindopril and indapamide at low dose improves endothelial function in essential hypertensive patients after acute administration.
Joannides R; Bellien J; Thurlure C; Iacob M; Abeel M; Thuillez C
Am J Hypertens; 2008 Jun; 21(6):679-84. PubMed ID: 18443573
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy of a converting enzyme inhibitor in the prevention of recurrence of stroke].
Masson C
Presse Med; 2001 Nov; 30(35):1716-7. PubMed ID: 11775593
[No Abstract] [Full Text] [Related]
10. [Level of endothelial vasodilatation and activity of angiotensin converting enzyme as criterion of efficacy of therapy in patients with mild and moderate hypertension].
Iakimenko ON; Gomazkov OA; Ektova TV; Aparina TV; Dilakian EA; Britov AN
Kardiologiia; 2005; 45(2):15-9. PubMed ID: 15798699
[No Abstract] [Full Text] [Related]
11. Perindopril + indapamide: new preparation. Simple trick.
Prescrire Int; 1999 Dec; 8(44):172-5. PubMed ID: 11503814
[TBL] [Abstract][Full Text] [Related]
12. [ADVANCE study: objectives, design and current status].
Chalmers J
Drugs; 2003; 63 Spec No 1():39-44. PubMed ID: 12708881
[TBL] [Abstract][Full Text] [Related]
13. [Type 2 diabetes: blood pressure lowering to 135/75 mmHg reduces mortality].
Einecke D
MMW Fortschr Med; 2007 Sep; 149(38):18. PubMed ID: 18018407
[No Abstract] [Full Text] [Related]
14. Combination of the angiotensin-converting enzyme inhibitor perindopril and the diuretic indapamide activate postnatal vasculogenesis in spontaneously hypertensive rats.
You D; Cochain C; Loinard C; Vilar J; Mees B; Duriez M; Lévy BI; Silvestre JS
J Pharmacol Exp Ther; 2008 Jun; 325(3):766-73. PubMed ID: 18309090
[TBL] [Abstract][Full Text] [Related]
15. Management of high blood pressure in type 2 diabetes: perindopril/indapamide fixed-dose combination and the ADVANCE trial [corrected].
Ghiadoni L
Expert Opin Pharmacother; 2010 Jul; 11(10):1647-57. PubMed ID: 20518617
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of treatment of hypertensive patients with fixed combination perindopril/indapamide up to 10/2.5 mg: results of the FALCO FORTE programme.
Pella D
High Blood Press Cardiovasc Prev; 2011 Sep; 18(3):107-13. PubMed ID: 21950782
[TBL] [Abstract][Full Text] [Related]
17. Persistence of the antihypertensive effect of low-dose combination therapy in mild hypertension.
Myers MG; Leenen FH;
Blood Press; 2006; 15(6):325-32. PubMed ID: 17472022
[TBL] [Abstract][Full Text] [Related]
18. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.
PROGRESS Collaborative Group
Lancet; 2001 Sep; 358(9287):1033-41. PubMed ID: 11589932
[TBL] [Abstract][Full Text] [Related]
19. New Premier study suggest Preterax as a first-line antihypertensive.
Cardiovasc J S Afr; 2004; 15(1):40-1. PubMed ID: 15095752
[No Abstract] [Full Text] [Related]
20. Blood pressure normalization by fixed perindopril/indapamide combination in hypertensive patients with or without associate metabolic syndrome: results of the OPTIMAX 2 study.
Mourad JJ; Lameira D; Guillausseau PJ
Vasc Health Risk Manag; 2008; 4(2):443-51. PubMed ID: 18561520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
